Merck's $11.5 Billion Bet on Its Next Big Drug Finally Arrives

News
0
Please log in or register to do it.


The newly approved drug, which treats potentially fatal pulmonary arterial hypertension, is estimated to ring up as much as $7.5 billion in yearly sales.



Your email address will not be published. Required fields are marked *

Engineers Raise Questions About Bridge’s Construction as Inquiry Begins
Father of three among Baltimore bridge victims